Anaesthesia for renal transplantation: an update

Vaibhavi Baxi, Anand Jain, D Dasgupta, Vaibhavi Baxi, Anand Jain, D Dasgupta

Abstract

Attempts at organ transplantation have been made since the 19(th) century. Renal transplantation is the preferred treatment for end stage renal disease. Renal transplant anaesthesia requires a thorough understanding of the metabolic and systemic abnormalities in end stage renal disease, familiarity with transplant medicine and expertise in managing and optimizing these patients for the best possible outcome. Also, the associated co-morbid conditions increase the complexity of anaesthesia, pain management and perioperative morbidity and mortality. Hence, a good perioperative management of these patients includes a multidisciplinary collaboration with well-planned anaesthetic strategies.

Keywords: Anaesthesia management; Cadaver donor; Living donor; Recipient; Renal transplantation.

References

    1. Onaca N, Goldstein RM, Levy MF, et al. Regional Transplant Institute: an update on liver, kidney, and pancreas transplantation. Proceedings from Baylor University Medical Center. 2003;16:297–301.
    1. Kasper DL, Braunwald E, Fauci AS. Harrison's principles of internal medecine. 16th ed. New York: McGraw-Hill; 2005. p. 1654.
    1. Krishnan M. Preoperative care of patients with kidney disease. Am Fam Physician. 2002;66:1471–1476.
    1. Vanholder R, Massy Z, Argiles A. Chronic kidney disease as a cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048–1056.
    1. Collins AJ, Brenner RM, Ofman JJ. Epoetin alpha use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. American Journal of Kidney Diseases. 2005;46:481–488.
    1. Stoelting RK, Dierdorf SF. Anesthesia and coexisting diseases. 4th ed. Philadelphia: Churchill Livingstone; 2002. pp. 347–348.
    1. Esposito C, Belloti N, Fasoli G. Hyperkalemia induced ECG abnormalities in patients with reduced renal function. Clinical Nephrology. 2004;62:465–468.
    1. Goodman WG. Calcium and phosphorus metabolism in patients who have chronic kidney disease. Medical Clinics of North America. 2005;89:631–647.
    1. Mannucci PM, Remuzzi C, Pusineri F. DDAVP shortens the bleeding time in uremia. New England Journal of Medicine. 1983;308:8.
    1. Malhotra V, Sudheendra V, Diwan S. Miller's Anesthesia. 6th Ed. Churchill Livingstone; 2005. Anesthesia and The Renal and Genitourinary Systems; pp. 2181–2187.
    1. Bateman DN, Gokal R. Metoclopromide in renal failure. Lancet. 1980;1:982.
    1. Ochs HR, Greenblatt DJ, Divoll M. Diazepam kinetics in patients with renal insuffiency or hyperthyroidism. Br J Clin. Pharmacol. 1981;12:829–832.
    1. Vinik Ronald H, Reves JG, Greenblatt, David J, Abernethy, Darrell R, Smith LR. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology. 1983;59:390–394.
    1. Verbeeck R, Tjandramaga TB, Verberckmoes R, DeSchepper PJ. Biotransformation and excretion of lorazepam in patients with chronic renal failure. Br Jr Clin Pharmacol. 1976;3:1033–1039.
    1. Burch PG, Stanski DR. Decreased protein binding and thiopental kinetics. Anesthesiology. 1983;59:215–9.
    1. Goyal P, Puri GD, Pandey CK. Evaluation of induction doses of Propofol: comparison between end stage renal disease and normal renal function patients. Anaesth Intensive Care. 2002;30:584–587.
    1. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28:497–504.
    1. Thapa S, Brull SJ. Succinylcholine induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg. 2000;91:237–241.
    1. Gentz BA, Malan TP. Renal toxicity of sevoflurane: a storm in a teacup? Drugs. 2001;61:2155–2162.
    1. Danovitch GM. Handbook of kidney transplantation. 4 th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. pp. 43–71.
    1. Halloran PF. Immunosupressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715–2729.
    1. Horgan S, Benedetti E, Moser F. Robotically assisted donor nephrectomy for kidney transplant. Am J Surg. 2004;188:45–51.
    1. Brunicardi FC, Anderson DK, Billiar TR. Schwartz's principles of surgery. 8 th ed. New York: McGraw-hill; 2005. p. 305.
    1. Sprung J, Kapural L, Bourke DL. Anaesthesia for kidney transplant. Anaesthesiol clin North America. 2000;18:919–951.
    1. Akpek E, Kayhan Z, Kaya H. Epidural anaesthesia for renal transplantation: A preliminary report. Transplant Proc. 1999;31:3149–3150.
    1. Linke CL, Merin RG. A regional anaesthetic approach for renal transplantation. Anesth Analg. 1976;55:69–73.
    1. Baker J, Yost SC, Niemann UC. Miller's anaesthesia. 6th ed. Philadelphia: Churchill Livingstone; 2005. Organ transplantation; pp. 2240–2241.
    1. Cozen PF, Nuscheler M, Melotte A. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anaesthesia sevoflurane or enflurane. Anesth Analg. 1995;81:569–575.
    1. Ferris RL, Kittur DS, Wilasrusmee C. Early hemodynamic changes after renal transplantation: determinants of low CVP in the recipients and correlation with acute renal dysfunction. Med Sci Monit. 2003;9:61–66.
    1. Gabriels G, August C, Grisk O. Impact of renal transplantation on small renal activity. Transplantation. 2003;75:689–697.
    1. Dawidson I, Berglin E, Brynger H. Intravascular volume and colloid dynamics in relation to fluid management in living related kidney donors and recipient. Crit Care Med. 1987;15:631–636.
    1. Kadieva VS, Friedman L, Margolius LP. The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth Analg. 1993;76:362–365.
    1. Knowles P, Hancox D, Letheren M. An evaluation of intercostals nerve blocks for analgesia following renal transplantation. Eur J Anaesthsiol. 1998;15:457–461.
    1. Divarkar D, Bailey Lynn RR. Long term complications following renal transplantation. N.Z. J. Med. 1991;104:352.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する